Company profile
Bicara Therapeutics Inc. Insider Trading
BCAXEvery SEC Form 4 insider trading filing for Bicara Therapeutics Inc. (BCAX) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Pharmaceutical Preparations
- CIK
- 0002023658
- Filings
- 84
- Insiders
- 35
- Last filing
- 2026-09-08
Activity summary
No discretionary insider buying or selling in the last 30 days. The 4 transactions filed were made under a 10b5-1 plan, scheduled in advance rather than decided on the day.
Three year balance
Buy and sell value by quarter, Q3 24 to Q3 26. Bicara Therapeutics Inc. insiders are net buyers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $40.5M.
90 day insight
Over the last 90 days, Bicara Therapeutics Inc. insiders bought $0 across 3 transactions with no open-market sales.
- Most active insider: Ryan Cohlhepp with 13 transactions totaling $2.0M.
- Largest single sale: $657K by Ryan Cohlhepp on Jul 8, 2026.
- 100% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.
Activity skews bullish — buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 8, 2026 | Ryan Cohlhepp | BCAX | Sale10b5 | 3,442 | $23.43 | $81K |
| Sep 8, 2026 | Ryan Cohlhepp | BCAX | Option Exercise10b5 | 17,500 | $3.79 | $66K |
| Sep 8, 2026 | Ryan Cohlhepp | BCAX | Option Exercise10b5 | 17,500 | — | — |
| Sep 8, 2026 | Ryan Cohlhepp | BCAX | Sale10b5 | 14,058 | $22.77 | $320K |
| Aug 12, 2026 | Jennifer Larson | BCAX | Award | 285,000 | — | — |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=BCAX" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.
Institutional Ownership
Top 13F-HR holders of Bicara Therapeutics Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →